Vyome Holdings, Inc. (HIND)
2.09
+0.06
(+2.96%)
USD |
NASDAQ |
Oct 09, 16:00
Vyome Holdings Enterprise Value : 8.062M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 8.062M |
| October 08, 2026 | 7.641M |
| October 07, 2026 | 7.711M |
| October 06, 2026 | 7.851M |
| October 05, 2026 | 6.939M |
| October 02, 2026 | 6.798M |
| October 01, 2026 | 6.868M |
| September 30, 2026 | 6.939M |
| September 29, 2026 | 7.570M |
| September 28, 2026 | 7.641M |
| September 25, 2026 | 7.711M |
| September 24, 2026 | 7.851M |
| September 23, 2026 | 7.500M |
| September 22, 2026 | 7.079M |
| September 21, 2026 | 6.939M |
| September 18, 2026 | 8.132M |
| September 17, 2026 | 7.149M |
| September 16, 2026 | 7.079M |
| September 15, 2026 | 7.500M |
| September 14, 2026 | 7.851M |
| September 11, 2026 | 7.851M |
| September 10, 2026 | 8.132M |
| September 09, 2026 | 7.851M |
| September 08, 2026 | 8.062M |
| September 04, 2026 | 8.974M |
| Date | Value |
|---|---|
| September 03, 2026 | 9.044M |
| September 02, 2026 | 8.693M |
| September 01, 2026 | 8.623M |
| August 31, 2026 | 8.554M |
| August 28, 2026 | 8.869M |
| August 27, 2026 | 8.904M |
| August 26, 2026 | 8.553M |
| August 25, 2026 | 9.044M |
| August 24, 2026 | 9.128M |
| August 21, 2026 | 9.185M |
| August 20, 2026 | 9.395M |
| August 19, 2026 | 9.676M |
| August 18, 2026 | 9.324M |
| August 17, 2026 | 9.325M |
| August 14, 2026 | 8.693M |
| August 13, 2026 | 8.553M |
| August 12, 2026 | 8.974M |
| August 11, 2026 | 9.185M |
| August 10, 2026 | 8.904M |
| August 07, 2026 | 8.553M |
| August 06, 2026 | 8.413M |
| August 05, 2026 | 8.413M |
| August 04, 2026 | 8.623M |
| August 03, 2026 | 8.588M |
| July 31, 2026 | 8.237M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cardiac Biotech Solutions, Inc. | 6.491M |
| Anika Therapeutics, Inc. | 248.88M |
| Enovis Corp. | 2.379B |
| Edwards Lifesciences Corp. | 45.69B |
| Perspective Therapeutics, Inc. | 70.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7197M |
| Revenue (Quarterly) | 0.027M |
| Total Expenses (Quarterly) | 0.7125M |
| EPS Diluted (Quarterly) | -0.0977 |
| Gross Profit Margin (Quarterly) | 33.33% |
| Profit Margin (Quarterly) | -2.67K% |
| Earnings Yield | -167.8% |
| Normalized Earnings Yield | -74.20 |